Clearmind Medicine Common Stock Today

CMND Stock  USD 1.22  0.03  2.40%   


3 of 100


Odds Of Distress

Less than 23

Clearmind Medicine is trading at 1.22 as of the 17th of April 2024, a -2.4% down since the beginning of the trading day. The stock's lowest day price was 1.21. Clearmind Medicine has about a 23 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Clearmind Medicine Common are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 18th of March 2024 and ending today, the 17th of April 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
16th of August 2021
Health Care
Clearmind Medicine is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 3.26 M outstanding shares of which 178.78 K shares are currently shorted by private and institutional investors with about 0.55 trading days to cover. More on Clearmind Medicine Common

Moving against Clearmind Stock

  0.45CELC Celcuity LLC Financial Report 20th of May 2024 PairCorr
  0.43MRNA Moderna Sell-off TrendPairCorr
  0.41INDP Indaptus Therapeutics Financial Report 9th of May 2024 PairCorr

Clearmind Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Clearmind Medicine's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Clearmind Medicine or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Thematic Ideas
(View all Themes)
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Health Care, NASDAQ Composite, Biotech, Health Management, IT, Health Care, Biotechnology, Biotechnology, Healthcare, Computing (View all Sectors)
Financial Strength
Based on the measurements of operating efficiency obtained from Clearmind Medicine's historical financial statements, Clearmind Medicine Common is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Clearmind Medicine Common is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities5.2 MM
Sufficiently Up
Slightly volatile
Total Assets6.3 MM
Sufficiently Up
Slightly volatile
Total Current Assets6.1 M5.8 M
Sufficiently Up
Slightly volatile
Clearmind Medicine's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Clearmind Medicine's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Clearmind Medicine's financial leverage. It provides some insight into what part of Clearmind Medicine's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Clearmind Medicine's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Clearmind Medicine deploys its capital and how much of that capital is borrowed.
Clearmind Medicine cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 52.4 K in liabilities. Clearmind Medicine Common has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Clearmind Medicine until it has trouble settling it off, either with new capital or with free cash flow. So, Clearmind Medicine's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Clearmind Medicine Common sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Clearmind to invest in growth at high rates of return. When we think about Clearmind Medicine's use of debt, we should always consider it together with cash and equity.

Net Borrowings

Clearmind Medicine Common (CMND) is traded on NASDAQ Exchange in USA. It is located in 1220 West 6th Avenue, Vancouver, BC, Canada, V6H 1A5 and employs 4 people. Clearmind Medicine is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.13 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Clearmind Medicine's market, we take the total number of its shares issued and multiply it by Clearmind Medicine's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Clearmind Medicine Common conducts business under Biotechnology sector and is part of Health Care industry. The entity has 3.26 M outstanding shares of which 178.78 K shares are currently shorted by private and institutional investors with about 0.55 trading days to cover. Clearmind Medicine Common currently holds about 1.65 K in cash with (6.3 M) of positive cash flow from operations.
Check Clearmind Medicine Probability Of Bankruptcy

Clearmind Stock Price Odds Analysis

What are Clearmind Medicine's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Clearmind Medicine jumping above the current price in 90 days from now is about 75.23%. The Clearmind Medicine Common probability density function shows the probability of Clearmind Medicine stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 3.0432 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Clearmind Medicine will likely underperform. Additionally, clearmind Medicine Common has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 1.22HorizonTargetOdds Above 1.22
24.68%90 days
Based on a normal probability distribution, the odds of Clearmind Medicine to move above the current price in 90 days from now is about 75.23 (This Clearmind Medicine Common probability density function shows the probability of Clearmind Stock to fall within a particular range of prices over 90 days) .

Clearmind Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Clearmind Medicine that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Clearmind Medicine's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Clearmind Medicine's value.
InstituionRecorded OnShares
Advisorshares Investments, Llc2023-12-31
92.7 K
Citadel Advisors Llc2023-09-30
14.7 K
Susquehanna International Group, Llp2023-12-31
O'dell Group2023-09-30
Warberg Asset Management Llc2023-12-31
Geode Capital Management, Llc2023-12-31
Tower Research Capital Llc2023-09-30
Two Sigma Securities, Llc2023-09-30
Walleye Trading Advisors, Llc2023-12-31
Hrt Financial Llc2023-09-30
View Clearmind Medicine Diagnostics

Clearmind Medicine Historical Income Statement

Clearmind Medicine Common Income Statement is one of the three primary financial statements used for reporting Clearmind's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Clearmind Medicine Common revenue and expense. Clearmind Medicine Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Clearmind Medicine's Cost Of Revenue is projected to increase significantly based on the last few years of reporting. The current year's Total Operating Expenses is expected to grow to about 8.8 M, whereas Gross Profit is projected to grow to (73.7 K). View More Fundamentals

Clearmind Stock Against Markets

Picking the right benchmark for Clearmind Medicine stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Clearmind Medicine stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Clearmind Medicine is critical whether you are bullish or bearish towards Clearmind Medicine Common at a given time. Please also check how Clearmind Medicine's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Clearmind Medicine without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Watchlist Optimization Now


Watchlist Optimization

Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
All  Next Launch Module

Clearmind Medicine Corporate Management

Elected by the shareholders, the Clearmind Medicine's board of directors comprises two types of representatives: Clearmind Medicine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Clearmind. The board's role is to monitor Clearmind Medicine's management team and ensure that shareholders' interests are well served. Clearmind Medicine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Clearmind Medicine's outside directors are responsible for providing unbiased perspectives on the board's policies.
BCom BCommCFO DirectorProfile
Gilad BabchukHead CommunicationProfile
Pr HadenVice DevelopmentProfile
Adi ZuloffShaniChief OfficerProfile

How to buy Clearmind Stock?

Before investing in Clearmind Medicine, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Clearmind Medicine. To buy Clearmind Medicine stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Clearmind Medicine. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Clearmind Medicine stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Clearmind Medicine Common stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Clearmind Medicine Common stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Clearmind Medicine Common, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Clearmind Stock please use our How to Invest in Clearmind Medicine guide.

Already Invested in Clearmind Medicine Common?

The danger of trading Clearmind Medicine Common is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Clearmind Medicine is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Clearmind Medicine. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Clearmind Medicine Common is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Clearmind Medicine Common is a strong investment it is important to analyze Clearmind Medicine's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearmind Medicine's future performance. For an informed investment choice regarding Clearmind Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearmind Medicine Common. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Clearmind Stock analysis

When running Clearmind Medicine's price analysis, check to measure Clearmind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearmind Medicine is operating at the current time. Most of Clearmind Medicine's value examination focuses on studying past and present price action to predict the probability of Clearmind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearmind Medicine's price. Additionally, you may evaluate how the addition of Clearmind Medicine to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Is Clearmind Medicine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearmind Medicine. If investors know Clearmind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearmind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Return On Assets
Return On Equity
The market value of Clearmind Medicine Common is measured differently than its book value, which is the value of Clearmind that is recorded on the company's balance sheet. Investors also form their own opinion of Clearmind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Clearmind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearmind Medicine's market value can be influenced by many factors that don't directly affect Clearmind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearmind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearmind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearmind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.